Prediction of the relationship between the structural features of andrographolide derivatives and α-glucosidase inhibitory activity: A quantitative structure-activity relationship (QSAR) Study

References

• Pili R, Chang J, Partis RA, Mueller RA, Chrest FJ, Passaniti A. The α-glucosidase I inhibitor castanospermine alters endothelial cell glycosylation, prevents angiogenesis, and inhibits tumor growth. Cancer Res 1995;55:2920–2926.
   PubMed Web of Science ®Google Scholar
• Humphries MJ, Matsumoto K, White SL, Olden K. Inhibition of experimental metastasis by castanospermine in mice: Blockage of two distinct stages of tumor colonization by oligosaccharide processing inhibitors. Cancer Res 1986;46:5215–5222.
   PubMed Web of Science ®Google Scholar
• Papandreou MJ, Barbouche R, Guieu R, Kieny MP, Fenouillet E. The α-glucosidase inhibitor 1-deoxynojirimycin blocks human immunodeficiency virus envelope glycoprotein-mediated membrane fusion at the CXCR4 binding step. Mol Pharmacol 2002;61:186–193.
   PubMed Web of Science ®Google Scholar
• Ouzounov S, Mehta A, Dwek RA, Block TM, Jordan R. The combination of interferon α-2b and n-butyl deoxynojirimycin has a greater than additive antiviral effect upon production of infectious bovine viral diarrhea virus (BVDV) in vitro: Implications for hepatitis C virus (HCV) therapy. Antiviral Res 2002;55:425–435.
   PubMedGoogle Scholar
• Kameda Y, Asano N, Yoshikawa M. Valiolamine, a new α-glucosidase inhibiting aminocyclitol produced by Streptomyces hygroscopicus. J Antibiotics 1984;37:1301–1307.
   PubMed Web of Science ®Google Scholar
• Robinson KM, Begovic ME, Rhinehart BL, Heineke EW, Ducep JB, Kastner PR, Marshall FN, Danzin C. New potent α-glucohydrolase inhibitor MDL 73945 with long duration of action in rats. Diabetes 1991;40:825–830.
   PubMed Web of Science ®Google Scholar
• Fujisawa T, Ikegami H, Inoue K, Kawabata Y, Ogihara T. Effect of two α-glucosidase inhibitors, voglibose and acarbose, on postprandial hyperglycemia correlates with subjective abdominal symptoms. Metab Clinic Exp 2005;54:387–390.
   PubMed Web of Science ®Google Scholar
• Van Den Broek LAGM, Kat-Van Den Nieuwenhof MWP, Butters TD, Van Boeckel CAA. Synthesis of α-glucosidase I inhibitors showing antiviral (HIV-1) and immunosuppressive activity. J Pharm Pharmacol 1996;48:172–178.
   PubMedGoogle Scholar
• Gui FD, Hai WX, Jun FW, Feng WL, Hong ML. Studies on the novel α-glucosidase inhibitory activity and structure–activity relationships for andrographolide analogues. Bioorg Med Chem Lett 2006;16:2710–2713.
   PubMedGoogle Scholar
• Silva CHTP, Taft CA. Computer aided molecular design of novel glucosidase inhibitors for AIDS treatment. J Biomol Struct Dyn 2004;22:59–63.
   PubMed Web of Science ®Google Scholar
• Fischer PB, Colin M, Karlson GB, James W, Butters TD, Davis SJ, Gordon S, Dwek RA, Platt FM. The α-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding. J Virol 1995;69:5791–5797.
   PubMed Web of Science ®Google Scholar
• Taylor DL, Kang MS, Brennan TM, Bridges CG, Sunkara PS, Tyms AS. Inhibition of α-glucosidase I of the glycoprotein-processing enzymes by 6-O-butanoyl Castanospermine (MDL 28,574) and its consequences in human immunodeficiency virus infected T cells. Antimicrob Agents Chemother 1994;38:1780–1787.
   PubMedGoogle Scholar
• Jung-Hum P, Sungmin K, Hwangseo P. Toward the virtual screening of α-glucosidase inhibitors with the homology-modelled protein structure. Bull Korean Chem Soc 2008;29:921–927.
   Google Scholar
• Hwangseo P, Kyo YH, Young HK, Kyung HO, Jae YL, Keun K. Discovery and biological evaluation of novel α-glucosidase inhibitors with in vivo antidiabetic effect. Bioorg Med Chem Lett 2008;18:3711–3715
   PubMedGoogle Scholar
• Rawling AJ, Lomas H, Adam WP, Marvin JRL, Dominic SA, Shane JSR, Sarah FJ, George WJF, Raymond AD, John HJ, Terry DB. Synthesis and biological characterization of novel N-alkyl deoxynojirimycin α-glucosidase inhibitors. ChemBioChem 2009;10:1101–1105.
   PubMedGoogle Scholar
• Kavitha B, Nagakumar B, Ki HP, Keun WL. Binding mode analyses and pharmacophore model development for sulphonamide chalcone derivatives, a new class of α-glucosidase inhibitors. J Mol Graph Model 2008;26:1202–1212.
   PubMedGoogle Scholar
• Tomich CH, da Silva P, Ivone C, Taft CA. Homology modelling and molecular interaction field studies of α-glucosidase as a guide to structure based drug design of novel proposed anti-HIV inhibitors. J Comput Aided Drug Des 2005;19:83–92.
   PubMed Web of Science ®Google Scholar
• Karthikeyan C, Moorthy NSHN, Trivedi P. QSAR study of substituted 2-pyridinyl quanidine as selective urokinase-type plasminogen activator (uPA) inhibitors. J Enz Inhib Med Chem 2009;24:6–13.
   PubMed Web of Science ®Google Scholar
• Xu HW, Dai GF, Liu GZ, Wang JF, Liu HM. Synthesis of andrographolide derivatives: A new family of α-glucosidase inhibitors. Bioorg Med Chem 2007;15:4247–4255.
   PubMed Web of Science ®Google Scholar
• Prasanna S, Manivannan E, Chaturvedi SC. Quantitative structure-activity relationship analysis of a series of 2,3-diaryl benzopyran analogues as novel selective cyclooxygenase-2 inhibitors. Bioorg Med Chem Lett 2004;14:4005–4011.
   PubMed Web of Science ®Google Scholar
• Chem BioOffice 2008, CambridgeSoft, Cambridge UK. 2008.
   Google Scholar
• MOE is a molecular modelling package developed by Chemical Computing Group, Montreal Canada. 2002.
   Google Scholar
• Systatica 8.0 statistical software, StatSoft, Tulsa, OK, USA. 2002.
   Google Scholar
• Balaji S, Karthikeyan C, Moorthy NSHN, Trivedi P. QSAR modelling of HIV-1 reverse transcriptase inhibition by benzoxazinones using a combination of P_VSA and pharmacophore feature descriptors. Bioorg Med Chem Lett 2004;14:6089–6094.
   PubMed Web of Science ®Google Scholar
• Cho DH, Lee SK, Kim BT, No KT. Quantitative Structure Activity relationship (QSAR) study of new fluorovinyloxyacetamides. Bull Korean Chem Soc 2001;22:388–394.
   Web of Science ®Google Scholar
• Durbin J, Watson GS. Testing for serial correlation in least squares regression. II. Biometrika 1951;38:159–178.
   PubMed Web of Science ®Google Scholar
• Tropsha A, Gramatica P, Gombar VK. The importance of earnest, validation is the absolute essential application and interpretation of QSPR models. QSAR Comb Sci 2003;22:69–77.
   Google Scholar
• Erikkson L, Jaworsha J, Worth AP, Mark TDC, Robert MM, Gramatica P. Methods for reliability and uncertainty assessment and for applicability evaluation of classification and regression based QSARs. Environ Health Perspect 2003;111:1361–1375.
   PubMedGoogle Scholar
• Alexander G, Alexander T. Beware of Q2. J Mol Graphs Model 2002;20:269–276.
   PubMed Web of Science ®Google Scholar
• Gramatica P. Principle of QSAR Model validation: internal and external. QSAR Comb Sci 2007;26:694–701.
   Google Scholar
• Cook RD. Influential observation in linear regression. J Am Stat Assoc 1979;74:169–174.
   Web of Science ®Google Scholar
• Rotriquez G. Chapter 2, Linear models for continuous data, 1993–2000:49–58 (Lecture Notes http://data.princeton.edu/wws509/notes )
   Google Scholar
• Dogra Shailay, K. Script for computing linear regression diagnostics from QSAR world-free online resources for QSAR modelling. (http://www.qsarworld.com/virtual-workshop.php)
   Google Scholar
• Wildman AS, Crippen GM. Prediction of physicochemical parameters by atomic contributions. J Chem Inf Comput Sci 1999;39:868–873.
   Google Scholar
• Cruciania G, Crivorib P, Carruptb P-A, Testa B. Molecular fields in quantitative structure–permeation relationships: The VolSurf approach. J Mol Struct (Theochem) 2000;503:17–30.
   Google Scholar
• http://www.moldiscovery.com/docs/volsurf/descriptors.html#AEN669
   Google Scholar
• Cruciani G, Pastor M, Guba W. Volsurf: a new tool for the pharmacokinetic optimization of lead compounds. Eur J Pharm Sci 2000;11:S29–S39.
   PubMed Web of Science ®Google Scholar
• Shahapurkar S, Kawathekar N, Chaturvedi SC. Quantitative structure activity relationship studies of diaryl thiophen derivatives as selective COX-2 inhibitors. Pharmazie 2005;60:254–258.
   PubMedGoogle Scholar
• Petitjean M. Applications of the radius-diameter diagram to the classification of topological and geometrical shapes of chemical compounds. J Chem Inf Comput Sci 1992;32:331–337.
   Google Scholar
• Petitjean M, Dubois JE. Topological statistics on a large structural file. J Chem Inf Comput Sci 1990;30:332–343.
   Google Scholar
• Iglika L, Andrew PW, Tatiana IN, John CD, Mark TDC. Quantitative structure–activity–activity and quantitative structure–activity investigations of human and rodent toxicity. Chemosphere 2006;65:1878–1887.
   PubMedGoogle Scholar
• Balasubramanian N, Avinash D, Vishnukant M. QSAR studies of 4,5-dihydro-4-oxo-3H-imidazo[4,5-c]pyridines as potent angiotensin II receptor antagonists by MLR and NLR analysis. ARKIVOC 2007;i:189–1204.
   Google Scholar
• Erol E, Hasan T, Semra G, Selami P, Oral O. A DFT-based QSARs study of acetazolamide/sulfanilamide derivatives with carbonic anhydrase (CA-II) isozyme inhibitory activity. Int J Mol Sci 2007;8:145–155.
   Google Scholar
• Gasteiger J, Marsili M. Iterative partial equalization of orbital electronegativity—a rapid access to atomic charges. Tetrahedron 1980;36:3219–3228.
   Web of Science ®Google Scholar
• Mulliken RS. A new electroaffinity scale; Together with data on valence states and on valence ionization potentials and electron affinities. J Chem Phys 1934;2:782–793.
   Google Scholar
• Gnanadesikan R, Kettenring JR. Robust estimate, residuals and outlier detection with multipurpose data. Biometrics 1972;28:81–124.
   Web of Science ®Google Scholar